Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

COPD

Drug for chronic obstructive pulmonary disease approved by NICE

Roflumilast (Daxas) has been approved by the National Institute of Health and Care Excellence (NICE) for the treatment of individuals with chronic obstructive pulmonary disease (COPD).

The drug, which is recommended as an option to treat adults with severe COPD whose symptoms continue to worsen despite other treatments, was initially reviewed by England’s health technology assessment body in 2012. However, limited data meant it was recommended only for patients participating in clinical trials.

Since then, two new trials have highlighted the effectiveness of roflumilast in easing hard-to-treat COPD symptoms, and consequently NICE decided to reviewed its guidance and to approve the drug — meaning that 122,000 eligible adults in England will now be able to receive it.

“This will be welcome news for many patients who have severe COPD symptoms that have been difficult to control,” says Carole Longson, director of the NICE centre for health technology evaluation. “COPD is a chronic lung condition which causes breathing problems and for many, symptoms will only worsen with time.”

Providing there are no appeals or factual inaccuracies raised by registered organisations, the final guideline will be published in July 2017 and roflumilast will be made available on the NHS within three months.

The US Food and Drug Administration approved the use of roflumilast for reducing COPD exacerbations in the USA in March 2011.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203049

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • older woman with chronic obstructive pulmonary disease

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.